Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

214studies shown

Showing 61-72 of 214

Drug study icon

CompletedNCT04895215

AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

AnxietyDrugFrom 5 Years to 17 Years

Countries: United States, Australia, New Zealand
Sponsor: Vertero Therapeutics
Condition: Anxiety

Drug study icon

CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

Bipolarity, DepressionDrugOver 18 Years

Countries: United States, Australia, India
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Bipolarity, Depression

Drug study icon

WithdrawnNCT01567124

Alleviating the Metabolic Side Effects of Antipsychotic Medications

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Australia
Sponsor: Baker Heart and Diabetes Institute
Condition: Schizophrenia

Other study type icon

Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaObservationalFrom 12 Years to 30 Years

Countries: United States, Australia, Canada, ...
Sponsor: Brigham and Women's Hospital
Condition: Schizophrenia

Drug study icon

CompletedNCT06215261

An Evaluation of the Safety and Efficacy of Methylone for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

PTSDDrugFrom 18 Years to 70 Years

Countries: United States, Australia, United Kingdom
Sponsor: Transcend Therapeutics
Condition: PTSD

Drug study icon

CompletedNCT00360126

An Extension Study Of Lamotrigine In Subjects With Bipolarity

This study is completed in Australia. It is testing lamotrigine for Bipolarity.

In Australia

BipolarityDrugOver 18 Years

Countries: Australia
Sponsor: GlaxoSmithKline
Condition: Bipolarity

Drug study icon

CompletedNCT01129882

An Rollover, Long-term Study of Aripiprazole Intramuscular Depot in people with Schizophrenia

This study is completed in the United States, in Australia, in Argentina, .... It is testing aripiprazole Intramuscular Depot for schizophrenia.

In Australia

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Australia, Argentina, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00206544

Anti-Estrogens - A Potential Treatment for Bipolarity in Women?

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

Bipolarity, SchizophreniaDrugFrom 18 Years to 50 Years

Countries: Australia
Sponsor: The Alfred
Condition: Bipolarity, Schizophrenia

Drug study icon

WithdrawnNCT05357040

Antidepressant Effects of Nitrous Oxide

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

DepressionDrugOver 18 Years

Countries: United States, Australia
Sponsor: University of Chicago
Condition: Depression

Other study type icon

Active Not RecruitingNCT07224347

Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

DepressionObservationalOver 65 Years

Countries: United States, Australia
Sponsor: Anne Murray
Condition: Depression

Behavioral study icon

CompletedNCT01110265

Attention Training and Its Effects on Body Image Disturbance

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

Eating disordersBehavioralFrom 18 Years to 37 Years

Countries: Australia
Sponsor: University of Sydney
Condition: Eating disorders

Drug study icon

CompletedNCT01358357

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

BipolarityDrugOver 18 Years

Countries: United States, Australia, France, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.